Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199754 · ClinicalTrials.gov registry record · Early Phase 1
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
A Early Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT04199754: Clinical Trial Early Phase 1 study, sponsored by Columbia University.
NCT04199754 is a Early Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 6 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04199754, a Early Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if giving intravenous (IV) contrast (a liquid that helps with the visibility of organs and blood vessels that is given through the vein with the use of a hollow needle) during a Cone Beam Computed Tomography (CBCT- a type of computerized X-ray) can help people who have image guided radiation therapy (IGRT) for the treatment of abdominal and pelvic tumors.
Primary Outcome
The Radiation Oncologist treating physician will complete a physician survey using a Likert scale regarding attitude about the utility of contrast enhanced cone beam CT.
Interventions
- RADIATION Radiation Therapy
- DRUG 0.9% Saline
- RADIATION Cone Beam CT
- DRUG Omnipaque 300mg/mL Solution for Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-05-28 |
| Phase | Early Phase 1 |
Why NCT04199754 stopped before completion
NCT04199754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 4 interventions - of which Radiation Therapy is the first listed.
NCT04199754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04199754 about?
NCT04199754 is a clinical study titled "IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy". The purpose of this study is to find out if giving intravenous (IV) contrast (a liquid that helps with the visibility of organs and blood vessels that is given through the vein with the use of a hollow needle) during a Cone Beam Computed Tomography (CBCT- a type of computerized X-ray) can help peopl...
What is the current status of trial NCT04199754?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2020-10-01. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04199754?
The interventions under investigation include: Radiation Therapy (RADIATION), 0.9% Saline (DRUG), Cone Beam CT (RADIATION), Omnipaque 300mg/mL Solution for Injection (DRUG).
Who is sponsoring clinical trial NCT04199754?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04199754's enrollment target sits among peer trials
6 1845th of 2000 higher than 114 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI